US Director of Medical Affairs - Breast Cancer

Merck

2d•Hybrid

About The Position

Role Summary The Breast USDMA is a US- based position within our Research & Development Division, US Medical Affairs. This position strategically drives scientific excellence across in-line business and our Company's One Pipeline while optimizing field readiness across the USMA strategic pillars: 1.) Scientific Exchange 2.) Company Trials 3.) Investigator-Sponsored Programs 4.) Congresses 5.) Insights The USDMA is an experienced therapeutic area (TA) leader and subject matter expert (SME) with relevant medical affairs and field medical experience. This role is also responsible for driving execution of scientific and medical affairs plans for assigned Therapy Areas within their region, engaging with regional cross-functional teams, and providing US input to the relevant cross-functional team meetings, e.g., US MAT, PAT, MT and V&I Plans. As a core member (or co-lead) of the US Medical Affairs Team (MAT), the USDMA collaborates with the Global Breast TA team and cross-functional partners to enable US regional implementation of Value & Implementation (V&I) Planning by: 1) Integrating local insights into Global Scientific Value Content (GSVC) and Center of Scientific Exchange Excellence (CSEE) plans 2) Facilitating local adoption of GSVC and CSEE initiatives 3) Leading development and execution of aligned local training programs 4) Evaluating training effectiveness and application in the field.

Requirements

An advanced degree (e.g., MD, PhD, PharmD) relevant to the TA-specific disease area and recognized medical expertise in the breast cancer.
A minimum of 5 years of medical affairs experience or equivalent clinical/research experience
A minimum of 3 years of working in breast cancer (clinical, research, or pharmaceutical environment) or within a highly relevant TA with demonstrated scientific acumen.
Proven ability in Strategic Decision Making & Planning, including helping the US Executive Director prioritize initiatives across the portfolio.
Demonstrated Execution Excellence with a track record of leading complex projects, managing multiple priorities simultaneously in a fast-paced environment.
Strong Emotional Intelligence to foster trust and respect within a complex, matrixed organizational structure.
Exceptional Networking & Partnerships skills to collaborate effectively across diverse teams and stakeholders.
Agile mindset as a Change Catalyst, committed to experimenting, learning, and adapting in response to evolving business needs, and capable of driving continuous improvement.
Expertise in interpreting and communicating complex scientific concepts clearly in both one-on-one and group settings.
Deep knowledge of the US healthcare system, including national treatment guidelines, clinical research processes, FDA regulations, and OIG compliance.
The ability to travel up to 40% (i.e.: Congresses and internal meetings)

Nice To Haves

Field Medical Affairs experience.
University-level teaching experience and understanding of adult learning principles.
Experience with innovative pharmaceutical training platforms.
Proficiency in Microsoft Word, PowerPoint, and Excel.
Ability to quickly assimilate new subject areas and work independently on complex problems

Responsibilities

In collaboration with USMA Executive Director (ED) and Health Systems PASL, conduct development and implementation of regional strategies aligned with headquarters V&I goals including defining a prioritized USMA Field strategy and implementation goals.
Contribute to the integrated US Country Medical Affairs Plan (CMAP), including the US Field Medical Plan (FMP)/Field Engagement Plan (FEP) and field training plan for assigned TA as a member of the USMA TA Leadership Team
Identifies and prioritizes US field resources, training needs and activities; and in collaboration with GMVC, ensures strategically aligned content and training and any other needed adult learning activities across the portfolio. This would also include the pull-through of pre- and post-congress regional training and content.
Develop a strategic and comprehensive scientific engagement plan and ensure scientific exchange aligns with the global scientific communications platform.
Ensure insights from advisory boards and field medical activities are actioned with relevant stakeholders, aligned with Country Medical Affairs priorities, and monitored for trends impacting future strategy.
In collaboration with relevant USMA stakeholders (e.g. HS PASL), organize expert input events (e.g., advisory boards, forums) with contracted Scientific Leaders and key stakeholders to address new indication implementation and/or emerging science.
Manage programs (i.e. patient support, education, risk management) as needed for appropriate and safe utilization of company medicines.
Partner with GSVC, CSEE, US Global Clinical Trial Organization (GCTO), Global Medical and Scientific Affairs (GMSA) TA leads, and internal/external SMEs to orchestrate and deliver regional training as needed.
Participate in bi-directional information exchange and sharing of best practices across USMA roles and teams, including Health Systems.
Collaborate with the USMA Field Medical Alignment Director (FMAD) to ensure consistent standards, processes, and harmonization for training activities (e.g., clinical immersions, verbalizations, journal clubs).
Provide input into strategic congress priorities and participate in planning at key scientific congresses.
Continuously monitor healthcare environment and emerging trends to optimize CMAPs and field execution plans.
Serve as a point of contact for development and maintenance of US new-hire scientific foundational onboarding in collaboration with leadership and SMEs.
Work with USMA Leadership and GMVC stakeholders to ensure consistent verbalization processes for new hires and tenured RMSDs regarding new data, indications, and disease areas.
Provide support for the Investigator Studies Program (ISP) for assigned TA, including Areas of Interest consultation, dissemination, data highlights, training, and scientific review as requested by the GMSA ED